Last Updated: November 13, 2026

Details for New Drug Application (NDA): 020911

« Back to Dashboard

NDA 020911 describes QVAR 80, which is a drug marketed by Teva Branded Pharm and is included in one NDA. There are two patents protecting this drug. Additional details are available on the QVAR 80 profile page.

The generic ingredient in QVAR 80 is beclomethasone dipropionate. There is one drug master file entry for this compound. Four suppliers are listed for this compound. Additional details are available on the beclomethasone dipropionate profile page.

Summary for 020911

Tradename:	QVAR 80
Applicant:	Teva Branded Pharm
Ingredient:	beclomethasone dipropionate
Patents:	2

Profile for product number 001

Active Rx/OTC/Discontinued:	DISCN	Dosage:	AEROSOL, METERED;INHALATION			Strength	0.08MG/INH Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons
Approval Date:	Sep 15, 2000	TE:		RLD:	Yes
Patent:	⤷ Start Trial	Patent Expiration:	May 18, 2031	Product Flag?	Y	Substance Flag?		Delist Request?	Y
Patent:	⤷ Start Trial	Patent Expiration:	May 18, 2031	Product Flag?	Y	Substance Flag?		Delist Request?	Y

Profile for product number 002

Active Rx/OTC/Discontinued:	DISCN	Dosage:	AEROSOL, METERED;INHALATION			Strength	0.04MG/INH Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons
Approval Date:	Sep 15, 2000	TE:		RLD:	Yes
Patent:	⤷ Start Trial	Patent Expiration:	May 18, 2031	Product Flag?	Y	Substance Flag?		Delist Request?	Y

Expired US Patents for NDA 020911

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Teva Branded Pharm	QVAR 40	beclomethasone dipropionate	AEROSOL, METERED;INHALATION	020911-002	Sep 15, 2000	⤷ Start Trial	⤷ Start Trial
Teva Branded Pharm	QVAR 80	beclomethasone dipropionate	AEROSOL, METERED;INHALATION	020911-001	Sep 15, 2000	⤷ Start Trial	⤷ Start Trial
Teva Branded Pharm	QVAR 40	beclomethasone dipropionate	AEROSOL, METERED;INHALATION	020911-002	Sep 15, 2000	⤷ Start Trial	⤷ Start Trial
Teva Branded Pharm	QVAR 40	beclomethasone dipropionate	AEROSOL, METERED;INHALATION	020911-002	Sep 15, 2000	⤷ Start Trial	⤷ Start Trial
Teva Branded Pharm	QVAR 80	beclomethasone dipropionate	AEROSOL, METERED;INHALATION	020911-001	Sep 15, 2000	⤷ Start Trial	⤷ Start Trial
Teva Branded Pharm	QVAR 80	beclomethasone dipropionate	AEROSOL, METERED;INHALATION	020911-001	Sep 15, 2000	⤷ Start Trial	⤷ Start Trial
Teva Branded Pharm	QVAR 80	beclomethasone dipropionate	AEROSOL, METERED;INHALATION	020911-001	Sep 15, 2000	⤷ Start Trial	⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.